INDIA IPO
Pharmaceuticals

Symbiotec Pharmalab Ltd

Indore, India

Complete IPO breakdown, price band, issue size, minimum lot size, GMP trends and listing timelines.

Total Issue Size

₹1757 Cr

Fresh: ₹150 Cr•OFS: ₹1607.00 Cr
Price Band

₹938 - ₹988

P/E Ratio: 56.81x

Lot Size & Min Investment

15 Shares

Min. Application: ₹14,820

Grey Market Premium (GMP)
₹200,240,250,250,285,352,340,340,403,345,320,265,205(20.2%)

Est. Listing Price: ₹1188

IPO Timelines & Key Dates

Issue Open Date
24 Aug 2026
Phase 1
Issue Close Date
27 Aug 2026
Phase 2
Basis of Allotment
28 Aug 2026
Phase 3
Initiation of Refunds
31 Aug 2026
Phase 4
Proposed Listing Date
01 Sept 2026
Phase 5 (Final)

Detailed IPO Specifications

Official Data
Issue Price Band₹938 - ₹988 per share
Total Issue Size₹1757 Cr
Fresh Issue Size₹150 Cr
Offer for Sale (OFS)₹1607.00 Cr
Minimum Retail Lot Size15 Shares
Min Retail Investment₹14,820
Stock Exchange(s)BSE, NSE
Issue Categorymainboard
Valuation P/E Ratio56.81x
Corporate HeadquartersIndore, India
Lead Manager(s)Jm Financial Limited
Registrar
MUFG Intime India (prev known as Linkintime India ) IPO Registrar

Listing Performance

Listing Price₹988
Listing Gain0.00%
NSE Closing Price₹1097.7
Expert Review

Detailed Analysis & GMP Forecast

Check complete fundamental review, subscription tracking, GMP updates and allotment status guide.

Read Full Blog Review
Information Disclaimer

Data is automatically synchronized with primary markets. Grey Market Premium (GMP) data is crowdsourced and provided strictly for educational purpose.

Symbiotec Pharmalab Ltd IPO Details, Size, PE Ratio, GMP | INDIA IPO